Evidence map›Paper›PMID 38108811›Full record

ArticleeLife2023

Opposing, spatially-determined epigenetic forces impose restrictions on stochastic olfactory receptor choice.

Elizaveta V Bashkirova, Nell Klimpert, Kevin Monahan, Christine E Campbell, Jason Osinski, Longzhi Tan, Ira Schieren, Ariel Pourmorady, Beka Stecky, Gilad Barnea and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 6 countries.

Elizaveta V BashkirovaIntegrated Program in Cellular, Molecular and Biomedical Studies, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, United States.
Nell KlimpertDepartment of Neuroscience, Division of Biology and Medicine and Robert J. and Nancy D. Carney Institute for Brain Science, Brown University, Providence, United States.ORCID 0000-0002-6166-8026
Kevin MonahanDepartment of Biochemistry and Molecular Biology, Rutgers University, Newark, United States.
Christine E CampbellDepartment of Biochemistry, University at Buffalo and New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, United States.
Jason OsinskiDepartment of Biochemistry, University at Buffalo and New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, United States.
Longzhi TanDepartment of Bioengineering, Stanford University, Stanford, United States.
Ira SchierenZuckerman Mind, Brain, and Behavior Institute, Columbia University, New York, United States.
Ariel PourmoradyIntegrated Program in Cellular, Molecular and Biomedical Studies, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, United States.
Beka SteckyZuckerman Mind, Brain, and Behavior Institute, Columbia University, New York, United States.
Gilad BarneaDepartment of Neuroscience, Division of Biology and Medicine and Robert J. and Nancy D. Carney Institute for Brain Science, Brown University, Providence, United States.ORCID 0000-0001-6842-3454
Xiaoliang Sunney XieBeijing Innovation Center for Genomics, Peking University, Beijing, China.
Ishmail Abdus-SaboorZuckerman Mind, Brain, and Behavior Institute, Columbia University, New York, United States.ORCID 0000-0003-2120-0063
Benjamin M ShykindPrevail Therapeutics- a wholly-owned subsidiary of Eli Lilly and Company, New York, United States.
Bianca J MarlinZuckerman Mind, Brain, and Behavior Institute, Columbia University, New York, United States.ORCID 0000-0002-4275-7891
Richard M GronostajskiDepartment of Biochemistry, University at Buffalo and New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, United States.
Alexander FleischmannDepartment of Neuroscience, Division of Biology and Medicine and Robert J. and Nancy D. Carney Institute for Brain Science, Brown University, Providence, United States.ORCID 0000-0001-7956-9096
Stavros LomvardasZuckerman Mind, Brain, and Behavior Institute, Columbia University, New York, United States.ORCID 0000-0002-7668-3026
Brain (Germany) · DEAllen Institute for Brain Science · USUniversity at Buffalo, State University of New York · USBioengineering Center · RUEli Lilly (United States) · USPioneer (United States) · USRutgers, The State University of New Jersey · US

Funding

The Structure of Olfactory Neural and Perceptual SpacesU19NS112953 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RINBERG, DMITRY · 2019 to 2023
$18.4M
Interdisciplinary Predoctoral Neuroscience Training Program in the Neuroscience Graduate Program.T32MH020068 · NIMH · BROWN UNIVERSITY · PI LIPSCOMBE, DIANE, SHEINBERG, DAVID L · 1999 to 2025
$7.6M
Deciphering nuclear bodies and compartments that govern singular olfactory receptor expression.U01DA040582 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BROWN, LEWIS M., LOMVARDAS, STAVROS · 2015 to 2019
$3.2M
Interrogating genome folding trajectories in health and diseaseU01DA052783 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOMVARDAS, STAVROS · 2020 to 2024
$3.1M
An olfactory subsystem that mediates innate behaviorsR01DC013561 · NIDCD · BROWN UNIVERSITY · PI BARNEA, GILAD · 2014 to 2018
$3.1M
Principles of zonal olfactory receptor gene expressionR01DC018745 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOMVARDAS, STAVROS · 2020 to 2024
$2.3M
Brain Science Compute ClusterS10OD025181 · OD · BROWN UNIVERSITY · PI SANES, JEROME N · 2019 to 2019
$600k
NIDA NIH HHS U01 DA040582NIDA NIH HHS U01 DA052783NIDCD NIH HHS R01 DC013561NIDCD NIH HHS R01DC013561NIDCD NIH HHS R01 DC018745NIDCD NIH HHS R01DC018745NIH HHS S10 OD025181NIMH NIH HHS T32 MH020068NINDS NIH HHS U19 NS112953
6 · The paper itself

Abstract

Olfactory receptor (OR) choice represents an example of genetically hardwired stochasticity, where every olfactory neuron expresses one out of ~2000 OR alleles in the mouse genome in a probabilistic, yet stereotypic fashion. Here, we propose that topographic restrictions in OR expression are established in neuronal progenitors by two opposing forces: polygenic transcription and genomic silencing, both of which are influenced by dorsoventral gradients of transcription factors NFIA, B, and X. Polygenic transcription of OR genes may define spatially constrained OR repertoires, among which one OR allele is selected for singular expression later in development. Heterochromatin assembly and genomic compartmentalization of OR alleles also vary across the axes of the olfactory epithelium and may preferentially eliminate ectopically expressed ORs with more dorsal expression destinations from this 'privileged' repertoire. Our experiments identify early transcription as a potential 'epigenetic' contributor to future developmental patterning and reveal how two spatially responsive probabilistic processes may act in concert to establish deterministic, precise, and reproducible territories of stochastic gene expression.

Indexed as

Olfactory Receptor NeuronsReceptors, OdorantAllelesAnimalsEpigenesis, GeneticEpigenomicsMiceReceptors, Odorantchromatindevelopmental biologygenomicsheterochromatinmousenuclear architectureolfactionpatterning

Identifiers

PMID38108811
PMCPMC10727497
OpenAlexW4376278500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.